The Chinese herb Tripterygium wilfordii Hook F for the treatment of systemic sclerosis-associated interstitial lung disease: data from a Chinese EUSTAR Center

被引：0
|
作者：
Luwei Yang
Qian Wang
Yong Hou
Jiuliang Zhao
Mengtao Li
Dong Xu
Xiaofeng Zeng
机构：
[1] Chinese Academy of Medical Sciences & Peking Union Medical College,Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital
来源：
Clinical Rheumatology | 2020年 / 39卷
关键词：
Cyclophosphamide; Interstitial lung disease; Systemic sclerosis; Hook F;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：813 / 821
页数：8
相关论文
共 50 条
  • [31] Treatment of systemic sclerosis-associated interstitial lung disease: Lessons from clinical trials
    Roofeh, David
    Distler, Oliver
    Allanore, Yannick
    Denton, Christopher P.
    Khanna, Dinesh
    JOURNAL OF SCLERODERMA AND RELATED DISORDERS, 2020, 5 (2_SUPPL) : 61 - 71
  • [32] PROGRESSIVE INTERSTITIAL LUNG DISEASE IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE
    Cuomo, G.
    Di Vico, C.
    Perretta, D.
    Iandoli, C.
    Ciaburri, R.
    Adamo, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1657 - 1658
  • [33] A phase I study of ethyl acetate extract of the Chinese antirheumatic herb Tripterygium wilfordii Hook F in rheumatoid arthritis
    Tao, XL
    Cush, JJ
    Garret, M
    Lipsky, PE
    JOURNAL OF RHEUMATOLOGY, 2001, 28 (10) : 2160 - 2167
  • [34] Continued treatment with nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from SENSCIS-ON
    Allanore, Yannick
    Vonk, Madelon C.
    Distler, Oliver
    Azuma, Arata
    Mayes, Maureen D.
    Gahlemann, Martina
    James, Alexandra
    Kohlbrenner, Veronika
    Alves, Margarida
    Khanna, Dinesh
    Highland, Kristin B.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (12) : 1722 - 1729
  • [35] Rationale for the evaluation of nintedanib as a treatment for systemic sclerosis-associated interstitial lung disease
    Wollin, Lutz
    Distler, Joerg H. W.
    Denton, Christopher P.
    Gahlemann, Martina
    JOURNAL OF SCLERODERMA AND RELATED DISORDERS, 2019, 4 (03) : 212 - 218
  • [36] The role of antifibrotic therapies in the treatment of systemic sclerosis-associated interstitial lung disease
    Boleto, Goncalo
    Avouac, Jerome
    Allanore, Yannick
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2022, 14
  • [37] Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
    Chung, Jonathan H.
    Walker, Christopher M.
    Hobbs, Stephen
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2020, (160): : na
  • [38] Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease REPLY
    Distler, Oliver
    Gahlemann, Martina
    Maher, Toby M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (16): : 1596 - 1597
  • [39] Personalized Medicine for Systemic Sclerosis-Associated Interstitial Lung Disease
    Ma, Angela
    Montesi, Sydney B.
    CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2025, 11 (01)
  • [40] Mycophenolate mofetil in systemic sclerosis-associated interstitial lung disease
    Athanasios Koutroumpas
    Athanasios Ziogas
    Ioannis Alexiou
    Georgia Barouta
    Lazaros I. Sakkas
    Clinical Rheumatology, 2010, 29 : 1167 - 1168
12345